UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 327

Sortiert nach

Novel therapeutic targets for inflammatory bowel disease

Journal of autoimmunity, 2017-12, Vol.85, p.103-116

2017

Link zum Volltext

Verfügbarkeit prüfen

A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies

Scientific reports, 2019-02, Vol.9 (1), p.2064-2064, Article 2064

2019

Link zum Volltext

Verfügbarkeit prüfen

Anti-TNF Biosimilars in Inflammatory Bowel Disease: Searching the Proper Patient's Profile

Current medicinal chemistry, 2019-01, Vol.26 (2), p.280

2019

Link zum Volltext

Verfügbarkeit prüfen

Tofacitinib in the treatment of ulcerative colitis: efficacy and safety from clinical trials to real-world experience

Therapeutic Advances in Gastroenterology, 2019, Vol.12, p.1756284819848631-1756284819848631

2019

Link zum Volltext

Verfügbarkeit prüfen

The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing Challenges

Frontiers in immunology, 2021-05, Vol.12, p.611256-611256

2021

Link zum Volltext

Verfügbarkeit prüfen

ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease-An Update

Journal of Crohn's and colitis, 2017-01, Vol.11 (1), p.26-34

2017

Link zum Volltext

Verfügbarkeit prüfen

Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study

Journal of Crohn's and colitis, 2018-11, Vol.12 (12), p.1385-1391

2018

Link zum Volltext

Verfügbarkeit prüfen

Calcium supplementation for the prevention of colorectal adenomas: a systematic review and meta-analysis of randomized controlled trials

World journal of gastroenterology : WJG, 2016-05, Vol.22 (18), p.4594-4603

2016

Link zum Volltext

Verfügbarkeit prüfen

Anti-IL-6 treatment for inflammatory bowel diseases: next cytokine, next target

Current drug targets, 2013-11, Vol.14 (12), p.1508

2013

Link zum Volltext

Verfügbarkeit prüfen

Absence of COVID-19 Infection in Patients Accessing IBD Unit at Humanitas, Milan: Implications for Postlockdown Measures

The American journal of gastroenterology, 2020-10, Vol.115 (10), p.1719-1721

2020

Link zum Volltext

Verfügbarkeit prüfen

The Experience with Biosimilars of Infliximab in Inflammatory Bowel Disease

Current pharmaceutical design, 2017-01, Vol.23 (44), p.6759

2017

Link zum Volltext

Verfügbarkeit prüfen

Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar‐treated IBD patients

Alimentary Pharmacology & Therapeutics (Suppl), 2019-05, Vol.49 (9), p.1181-1187

2019

Link zum Volltext

Verfügbarkeit prüfen

Proactive TDM for Crohn’s Disease Patients in Clinical Remission Under Anti-TNF Treatment: Current State of Evidence

Journal of Crohn's and colitis, 2020-09, Vol.14 (9), p.1338-1339

2020

Link zum Volltext

Verfügbarkeit prüfen

Research Gaps in Diet and Nutrition in Inflammatory Bowel Disease. A Topical Review by D-ECCO Working Group [Dietitians of ECCO]

Journal of Crohn's and colitis, 2017-12, Vol.11 (12), p.1407-1419

2017

Link zum Volltext

Verfügbarkeit prüfen

Adalimumab and Azathioprine Combination Therapy for Crohn’s Disease: A Shining Diamond?

Journal of Crohn's and colitis, 2016-11, Vol.10 (11), p.1257-1258

2016

Link zum Volltext

Verfügbarkeit prüfen

First-line therapy in adult Crohn's disease: who should receive anti-TNF agents?

Nature reviews. Gastroenterology & hepatology, 2013-06, Vol.10 (6), p.345

2013

Link zum Volltext

Verfügbarkeit prüfen

MFSD2A Promotes Endothelial Generation of Inflammation-Resolving Lipid Mediators and Reduces Colitis in Mice

Gastroenterology (New York, N.Y. 1943), 2017-11, Vol.153 (5), p.1363-1377.e6

2017

Link zum Volltext

Verfügbarkeit prüfen

The biosimilar road in inflammatory bowel disease: The right way?

Baillière's best practice & research. Clinical gastroenterology, 2014-06, Vol.28 (3), p.465-471

2014

Link zum Volltext

Verfügbarkeit prüfen

SFED recommendations for IBD endoscopy during COVID-19 pandemic: Italian and French experience

Nature reviews. Gastroenterology & hepatology, 2020-08, Vol.17 (8), p.507-516

2020

Link zum Volltext

Verfügbarkeit prüfen

Gastrointestinal System: COVID-19 and Potential Mechanisms Associated with Coagulopathy

Current drug targets, 2022-01, Vol.23 (17), p.1611

2022

Link zum Volltext

Verfügbarkeit prüfen

Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn’s Disease

Gastroenterology (New York, N.Y. 1943), 2018-07, Vol.155 (1), p.76-87

2018

Link zum Volltext

Verfügbarkeit prüfen

Rediscovering histology: what is new in endoscopy for inflammatory bowel disease?

Therapeutic Advances in Gastroenterology, 2021, Vol.14, p.17562848211005692-17562848211005692

2021

Link zum Volltext

Verfügbarkeit prüfen

Anti-fibrotic Drugs for Crohn's Disease: Ready for Prime Time?

Current pharmaceutical design, 2019-01, Vol.25 (1), p.47

2019

Link zum Volltext

Verfügbarkeit prüfen

Iron deficiency anemia impacts disease progression and healthcare resource consumption in patients with inflammatory bowel disease: a real-world evidence study

Therapeutic advances in gastroenterology, 2023-01, Vol.16, p.17562848231177153-17562848231177153

2023

Link zum Volltext

Verfügbarkeit prüfen

Familial aggregation in inflammatory bowel disease：Is it genes or environment

World journal of gastroenterology : WJG, 2011-06, Vol.17 (22), p.2715-2722

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 327

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(315)
Mit Volltextzugriff
(258)

Publikationsform

Sprache

Englisch
(327)
Japanisch
(26)

Erscheinungsjahr

n.n

Thema

Science & Technology
(228)
Life Sciences & Biomedicine
(225)
Humans
(175)
Gastroenterology & Hepatology
(151)
Inflammatory Bowel Disease
(114)
Ulcerative Colitis
(83)
Crohn's Disease
(77)
Female
(58)
Adult
(56)
Gastroenterology And Hepatology
(56)
Male
(55)
Middle Aged
(41)
Colitis, Ulcerative - Drug Therapy
(36)
Crohn’s Disease
(36)
Pharmacology & Pharmacy
(34)
Crohn Disease - Drug Therapy
(33)
Treatment Outcome
(33)
Gastroenterology
(32)
Inflammatory Bowel Diseases - Drug Therapy
(31)
Life Sciences
(28)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Novel therapeutic targets for inflammatory bowel disease

A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies

Anti-TNF Biosimilars in Inflammatory Bowel Disease: Searching the Proper Patient's Profile

Tofacitinib in the treatment of ulcerative colitis: efficacy and safety from clinical trials to real-world experience

The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing Challenges

ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease-An Update

Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study

Calcium supplementation for the prevention of colorectal adenomas: a systematic review and meta-analysis of randomized controlled trials

Anti-IL-6 treatment for inflammatory bowel diseases: next cytokine, next target

Absence of COVID-19 Infection in Patients Accessing IBD Unit at Humanitas, Milan: Implications for Postlockdown Measures

The Experience with Biosimilars of Infliximab in Inflammatory Bowel Disease

Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar‐treated IBD patients

Proactive TDM for Crohn’s Disease Patients in Clinical Remission Under Anti-TNF Treatment: Current State of Evidence

Research Gaps in Diet and Nutrition in Inflammatory Bowel Disease. A Topical Review by D-ECCO Working Group [Dietitians of ECCO]

Adalimumab and Azathioprine Combination Therapy for Crohn’s Disease: A Shining Diamond?

First-line therapy in adult Crohn's disease: who should receive anti-TNF agents?

MFSD2A Promotes Endothelial Generation of Inflammation-Resolving Lipid Mediators and Reduces Colitis in Mice

The biosimilar road in inflammatory bowel disease: The right way?

SFED recommendations for IBD endoscopy during COVID-19 pandemic: Italian and French experience

Gastrointestinal System: COVID-19 and Potential Mechanisms Associated with Coagulopathy

Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn’s Disease

Rediscovering histology: what is new in endoscopy for inflammatory bowel disease?

Anti-fibrotic Drugs for Crohn's Disease: Ready for Prime Time?

Iron deficiency anemia impacts disease progression and healthcare resource consumption in patients with inflammatory bowel disease: a real-world evidence study

Familial aggregation in inflammatory bowel disease：Is it genes or environment

Suchergebnisse filtern